Top

Published in:

01-04-2016 | Review article

Percutaneous biopsy facilitates modern treatment of renal masses

Author: E. Jason Abel

Published in: Abdominal Radiology | Issue 4/2016

Abstract

Contemporary approaches to cancer therapy have moved away from a one-size-fits-all model. Precision treatments are based on patients and their individual tumor characteristics. In general, incidental renal masses fall into three categories: aggressive cancers, indolent cancers, and benign tumors. Treatments may include surgery, thermal ablation, or observation. Choosing the best treatment based solely on radiologic information is uninformed and unnecessary, and may lead to overtreatment of benign tumors or inappropriate treatment of aggressive tumors. Percutaneous biopsy is a safe and effective tool that provides prognostic information about unknown masses to guide treatment decision making. The first step for improving personalized treatments for small renal masses is clear: increase utilization of pretreatment renal mass biopsy.

Frank I, Blute ML, Cheville JC, et al. (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170(6 Pt 1):2217–2220. doi:10.1097/01.ju.0000095475.12515.5e CrossRefPubMed

Johnson DC, Vukina J, Smith AB, et al. (2015) Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol 193(1):30–35. doi:10.1016/j.juro.2014.07.102 CrossRefPubMed

Blute ML Jr, Drewry A, Abel EJ (2015) Percutaneous biopsy for risk stratification of renal masses. Ther Adv Urol 7(5):265–274. doi:10.1177/1756287215585273 CrossRefPubMedPubMedCentral

Tan HJ, Norton EC, Ye Z, et al. (2012) Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 307(15):1629–1635. doi:10.1001/jama.2012.475 CrossRefPubMed

Marconi L, Dabestani S, Lam TB, et al. (2015) Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol . doi:10.1016/j.eururo.2015.07.072

Heilbrun ME, Yu J, Smith KJ, et al. (2012) The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a Markov model. J Urol 187(1):39–43. doi:10.1016/j.juro.2011.09.055 CrossRefPubMed

Ball MW, Bezerra SM, Gorin MA, et al. (2015) Grade heterogeneity in small renal masses: potential implications for renal mass biopsy. J Urol 193(1):36–40. doi:10.1016/j.juro.2014.06.067 CrossRefPubMed

Ginzburg S, Uzzo R, Al-Saleem T, et al. (2014) Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy. J Urol 191(2):296–300. doi:10.1016/j.juro.2013.07.059 CrossRefPubMedPubMedCentral

Prince J, Bultman E, Hinshaw L, et al. (2015) Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol 193(6):1899–1904. doi:10.1016/j.juro.2014.12.021 CrossRefPubMedPubMedCentral

10.

Leppert JT, Hanley J, Wagner TH, et al. (2014) Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology 83(4):774–779. doi:10.1016/j.urology.2013.10.073 CrossRefPubMedPubMedCentral

11.

Volanis D, Neal DE, Warren AY, Gnanapragasam VJ (2015) Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literature. BJU Int 115(5):698–704. doi:10.1111/bju.12849 CrossRefPubMed

12.

Hung AJ, Cai J, Simmons MN, Gill IS (2013) “Trifecta” in partial nephrectomy. J Urol 189(1):36–42. doi:10.1016/j.juro.2012.09.042 CrossRefPubMed

13.

Choueiri TK, Schutz FA, Hevelone ND, et al. (2011) Thermal ablation vs surgery for localized kidney cancer: a surveillance, epidemiology, and end results (SEER) database analysis. Urology 78(1):93–98. doi:10.1016/j.urology.2011.01.068 CrossRefPubMed

14.

Atwell TD, Schmit GD, Boorjian SA, et al. (2013) Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 200(2):461–466. doi:10.2214/AJR.12.8618 CrossRefPubMed

15.

Abel EJ, Bauman TM, Weiker M, et al. (2014) Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression. Hum Pathol 45(5):1092–1099. doi:10.1016/j.humpath.2014.01.008 CrossRefPubMedPubMedCentral

Title: Percutaneous biopsy facilitates modern treatment of renal masses
Author: E. Jason Abel
Publication date: 01-04-2016
Publisher: Springer US
Published in: Abdominal Radiology / Issue 4/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-016-0644-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Percutaneous biopsy facilitates modern treatment of renal masses

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2016

Percutaneous image-guided cryoablation of small renal masses

Hepatic imaging following intra-arterial embolotherapy

Optimizing modality selection for image-guided procedures: an analysis of the challenges to ultrasound guidance

Abdominal radiology in the era of the Interventional Radiology/Diagnostic Radiology certificate

Introduction to the special section on interventional abdominal radiology

Microwave ablation for liver tumors

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page